[Participation and support of clinical studies and other scientific investigations. Statement of the German Society for Pathology]

Pathologe. 2013 Sep;34(5):466-75. doi: 10.1007/s00292-013-1793-y.
[Article in German]

Abstract

Clinical studies and preclinical investigations are essential in order to test new therapies and diagnostics with the aim of sustained improvement in the treatment of patients. Fortunately, the number of clinical studies is continuously increasing and pathology and tissue-based research are included more often. The German Society for Pathology (DGP) and the pathologists it represents want to and can support this process and our clinical partners as best as possible as an equal partner. With our technologies and our specific expertise we can make a substantial contribution to the quality and the success of preclinical investigations, clinical studies and implementation of the results into clinical pathological diagnostics. In order to support this process the DGP has formulated a statement on the participation and support of clinical studies and other scientific investigations.

Publication types

  • English Abstract

MeSH terms

  • Biomarkers / analysis
  • Clinical Trials as Topic*
  • Clinical Trials, Phase I as Topic
  • Germany
  • Humans
  • Pathology*
  • Predictive Value of Tests
  • Quality Assurance, Health Care
  • Societies, Medical*

Substances

  • Biomarkers